Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VBI Vaccines Inc VBIVQ

Healthcare Biotechnology
VBI Vaccines Inc. is a commercial-stage biopharmaceutical company. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology and a proprietary mRNA-launched eVLP (MLE) platform technology, the Company develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The... see more

Recent & Breaking News (PINL:VBIVQ)

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of VBI Vaccines Inc. And Encourages Investors To Contact The Firm For Additional Information

Business Wire October 29, 2015

Lifshitz & Miller Law Firm Announces Investigation of Media General, Inc., Piedmont Natural Gas Co., Rite Aid Corporation, Security California Bancorp, Southcoast Financial Corp., The Pep Boys - Manny, Moe & Jack, TriVascular Technologies, Inc. and VBI Vaccines Inc.

PR Newswire October 29, 2015

Why the SciVac VBI Merger Makes a Lot of Sense

Accesswire October 28, 2015

VBI SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of VBI Vaccines Inc. (VBIV) Over the Proposed Sale of the Company to SciVac Therapeutics Inc.

Business Wire October 28, 2015

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of VBI Vaccines Inc. And Encourages Investors To Contact The Firm For Additional Information

Business Wire October 27, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of VBI Vaccines Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to SciVac Therapeutics Inc. -- VBIV

PR Newswire October 27, 2015

VBI VACCINES INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to SciVac Therapeutics Inc.

Business Wire October 26, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of VBI Vaccines Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to SciVac Therapeutics Inc.

Business Wire October 26, 2015

VBI Vaccines Announces Development of a Novel Glioblastoma Immunotherapy Candidate

GlobeNewswire October 8, 2015

VBI Vaccines to Present at the 15th Annual Biotech in Europe Forum

GlobeNewswire September 24, 2015

VBI Vaccines Promotes Dr. David E. Anderson to Chief Scientific Officer

GlobeNewswire September 14, 2015

VBI Vaccines Awarded NRC-IRAP Funding to Leverage its eVLP Platform in the Development of a Novel RSV Vaccine Candidate

GlobeNewswire September 8, 2015

VBI Vaccines to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

GlobeNewswire September 3, 2015

VBI Vaccines to Provide an Update on its CMV Vaccine Program at the Tenth Annual IMVACS Summit

GlobeNewswire August 26, 2015

VBI Vaccines Announces Closing of $6.29 Million Private Placement

GlobeNewswire August 18, 2015

VBI Vaccines to Present at the 2015 BIO International Convention

GlobeNewswire June 9, 2015

VBI Vaccines Presents Data at the World Vaccine Congress Asia That Supports the Potential Use of Its eVLP Platform in the Development of a Novel Hepatitis C Vaccine Candidate

GlobeNewswire June 3, 2015

VBI Vaccines to Discuss the Manufacture of Enveloped Virus-Like Particles at the Modern Vaccines Adjuvants & Delivery Systems Conference

GlobeNewswire May 15, 2015

VBI Vaccines Announces New Data Supporting the Manufacture of Its Prophylactic CMV Vaccine Candidate

GlobeNewswire April 9, 2015

VBI Vaccines Announces Research Collaboration With Sanofi Pasteur to Enhance Vaccine Stability

GlobeNewswire April 6, 2015